Get the Stockscreener App
11.30
1.16%
0.13
After Hours:
11.25
-0.05
-0.44%
Anavex Life Sciences Corporation stock is traded at $11.30, with a volume of 1.49M.
It is up +1.16% in the last 24 hours and up +22.56% over the past month.
Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.
See More
Previous Close:
$11.17
Open:
$11.15
24h Volume:
1.49M
Relative Volume:
1.51
Market Cap:
$965.21M
Revenue:
-
Net Income/Loss:
$-43.16M
P/E Ratio:
-20.55
EPS:
-0.55
Net Cash Flow:
$-29.31M
1W Performance:
-11.30%
1M Performance:
+22.56%
6M Performance:
+21.90%
1Y Performance:
+66.30%
1-Day Range:
$11.15
$12.68
1-Week Range:
$10.93
$12.80
52-Week Range:
$4.9301
$14.44
Anavex Life Sciences Corporation Stock (AVXL) Company Profile
Name
Anavex Life Sciences Corporation
Sector
Industry
Phone
844-689-3939
Address
630 5TH AVENUE, NEW YORK
Compare AVXL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVXL
Anavex Life Sciences Corporation
|
11.30 | 954.10M | 0 | -43.16M | -29.31M | -0.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.87 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.46 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
392.24 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
670.33 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
301.13 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Anavex Life Sciences Corporation Stock (AVXL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-22 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-23-22 | Initiated | Berenberg | Buy |
| Sep-23-21 | Initiated | BTIG Research | Buy |
| Dec-16-20 | Reiterated | H.C. Wainwright | Buy |
| Sep-28-20 | Initiated | Ladenburg Thalmann | Buy |
| Feb-27-20 | Initiated | Cantor Fitzgerald | Overweight |
| Jun-18-19 | Initiated | Janney | Buy |
| May-16-18 | Resumed | Maxim Group | Buy |
| Mar-08-18 | Initiated | ROTH Capital | Buy |
| Feb-13-18 | Reiterated | Maxim Group | Buy |
| Sep-29-17 | Resumed | Noble Financial | Buy |
| Feb-07-17 | Initiated | Noble Financial | Buy |
| Mar-29-16 | Initiated | FBR Capital | Outperform |
View All
Anavex Life Sciences Corporation Stock (AVXL) Latest News
Anavex Life Sciences: Early Blarcamesine Treatment Cuts Alzheimer's Progression by 20 Months - AOL.com
Breakthrough: New Alzheimer's Drug Saves Patients Nearly 20 Months of Disease Progression in Clinical Trial - Stock Titan
Is it the right time to buy Anavex Life Sciences Corp. stockFree Stock Forecasts That Work - jammulinksnews.com
Real time social sentiment graph for Anavex Life Sciences Corp.Pattern Detection for Entry Confirmation Enabled - metal.it
Visual analytics tools that track Anavex Life Sciences Corp. performanceFree Weekly Chart Analysis With Entry Advice - Newser
Sheaff Brock Investment Advisors LLC Reduces Stake in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Anavex Life Sciences Corp. (NASDAQ:AVXL) Shares Acquired by Bank of New York Mellon Corp - Defense World
Is Anavex Life Sciences Corp. stock a growth or value playWeekly Setup Summary for Risk Controlled Trades - Newser
What data driven models say about Anavex Life Sciences Corp.’s futureHigh Conviction Screener with Trend Matching - Newser
Risk adjusted return profile for Anavex Life Sciences Corp. analyzedGrowth Summary Based on Market Positioning - Newser
Anavex Life Sciences Corp. Pullback Analyzed — Is It Time to ExitDaily Growth Stock Pick Reports Show Bullish Signals - metal.it
AI Tools Suggest Anavex Life Sciences Corp. May Outperform This WeekSwing Setup With Technical Confirmation Explained - metal.it
What is the dividend policy of Anavex Life Sciences Corp. stockSuperior trading gains - jammulinksnews.com
What institutional investors are buying Anavex Life Sciences Corp. stockRapid market gains - jammulinksnews.com
What data driven models say about Anavex Life Sciences Corp.’s future Short-Term Support and Resistance Forecast - Newser
What are analysts’ price targets for Anavex Life Sciences Corp. in the next 12 monthsInvest confidently with market-leading analysis - jammulinksnews.com
What catalysts could drive Anavex Life Sciences Corp. stock higher in 2025Discover undervalued opportunities early - jammulinksnews.com
Sectors Driving Future Growth for Anavex Life Sciences Corp. StockFree Investment Group - Newser
Key External Factors That Drive Anavex Life Sciences Corp. Stock Price MovementsTargeted 200 Percent Gain - Newser
What analysts say about Anavex Life Sciences Corp. stockFree Advanced Stock Screener Access - PrintWeekIndia
What drives Anavex Life Sciences Corp. stock priceRapid growth opportunities - PrintWeekIndia
Anavex Life Sciences Corp. Stock Analysis and ForecastExceptional financial outcomes - Autocar Professional
Why Anavex Life Sciences Corp. stock attracts strong analyst attentionFree Stock Market Return Analysis - Newser
Is Anavex Life Sciences Corp. a good long term investmentRapid growth opportunities - Autocar Professional
Anavex Life Sciences (AVXL) Is Up 19.1% After $300M Shelf Registration Filing Has The Bull Case Changed? - simplywall.st
Arizona State Retirement System Makes New Investment in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
Teacher Retirement System of Texas Acquires New Shares in Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
How Anavex Life Sciences Corp. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
Anavex Life Sciences Corporation Stock (AVXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.43%
2.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):